Skip to content

Effect of nalbuphine on postoperative gastrointestinal function in patients undergoing gynecological malignant tumor radical surgery

Effect of nalbuphine on postoperative gastrointestinal function in patients undergoing gynecological malignant tumor radical surgery

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IPR-17011658
Enrollment
Unknown
Registered
2017-06-14
Start date
2017-06-01
Completion date
Unknown
Last updated
2017-06-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postoperative gastrointestinal function in patients undergoing gynecological malignant tumor radical surgery

Interventions

Experimental group:Perioperative using nalbuphine for perioperative analgesia
control group:Perioperative using sufentanil for perioperative analgesia

Sponsors

Obstetrics and Gynecology Hospital of Fudan University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. patients aging 18-70 years old, udergoing laparoscopic gynecological malignancy radical surgery; 2. patients with ASA ranging from grade I to grade II.

Exclusion criteria

Exclusion criteria: 1. patient with opioid allergy; 2. patient with preoperative liver dysfunction (ALT> 66U/L or AST> 36U/L); 3. patient with preoperative renal dysfunction (creatinine> 106umol/L or urea nitrogen> 6.1mmol/L); 4. patient with abnormal history of abnormal anesthesia; 5. patient with esophageal reflux disease; 6. patient who used sedatives or antiemetic medicine in 24 hours; 7. Shock patient; 8. patients with chronic obstructive pulmonary disease (COPD); 9. patient who can not understand the visual fuzzy score (VAS); 10. patient who can not understand how to use intravenous controlled analgesia (PCA); 11. patients refusing to participate in this study.

Design outcomes

Primary

MeasureTime frame
First exhaust time;First defecation time;

Secondary

MeasureTime frame
First time to eat;The number of nausea during postoperative 48 hours;The number of vomit during postoperative 48 hours;VAS score at 6 hours after operation;VAS score at 12 hours after operation;VAS score at 24 hours after operation;VAS score at 48 hours after operation;Number of hospitalized days;Serum gastrin measured 24 hours before and after surgery;

Countries

China

Contacts

Public ContactJiao Jing

Obstetrics and Gynecology Hospital of Fudan University

jjjiaojing@126.com+86 13817416181

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026